Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1341

1.

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.

Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.

Cancer Chemother Pharmacol. 2008 Sep;62(4):621-9. Epub 2007 Nov 24.

PMID:
18038274
2.

Preclinical anti-tumor activity of XR5944 in combination with carboplatin or doxorubicin in non-small-cell lung carcinoma.

Harris SM, Scott JA, Brown JL, Charlton PA, Mistry P.

Anticancer Drugs. 2005 Oct;16(9):945-51.

PMID:
16162971
3.

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.

Clin Cancer Res. 2000 May;6(5):2075-86.

5.

Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.

Matsumoto S, Igishi T, Hashimoto K, Kodani M, Shigeoka Y, Nakanishi H, Touge H, Kurai J, Makino H, Takeda K, Yasuda K, Hitsuda Y, Shimizu E.

Int J Oncol. 2004 Nov;25(5):1311-8.

PMID:
15492820
6.

Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma.

Carter CA, Chen C, Brink C, Vincent P, Maxuitenko YY, Gilbert KS, Waud WR, Zhang X.

Cancer Chemother Pharmacol. 2007 Feb;59(2):183-95. Epub 2006 May 25.

PMID:
16724239
7.

Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.

Mattern J, Wayss K, Volm M.

In Vivo. 1987 Jan-Feb;1(1):23-6.

PMID:
2856516
8.

[Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].

Tang CH, Liu XQ, Yang SF, Zhu B, Gao HJ.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):808-12. Chinese.

PMID:
19173823
9.

Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.

Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR.

Clin Cancer Res. 2009 Feb 15;15(4):1232-40. doi: 10.1158/1078-0432.CCR-08-0810. Epub 2009 Jan 27.

10.
11.

In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.

Webb MS, Johnstone S, Morris TJ, Kennedy A, Gallagher R, Harasym N, Harasym T, Shew CR, Tardi P, Dragowska WH, Mayer LD, Bally MB.

Eur J Pharm Biopharm. 2007 Mar;65(3):289-99. Epub 2006 Oct 17.

PMID:
17123800
12.

The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.

Hermann TW, Yen WC, Tooker P, Fan B, Roegner K, Negro-Vilar A, Lamph WW, Bissonnette RP.

Lung Cancer. 2005 Oct;50(1):9-18.

PMID:
15993980
13.

Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.

Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D.

Cancer Chemother Pharmacol. 2007 May;59(6):725-32. Epub 2006 Sep 12.

PMID:
16967299
14.

Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.

Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.

Clin Cancer Res. 1999 Jul;5(7):1905-17.

15.
16.

[Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].

Uchida J, Satake H, Saito H, Nakano K, Takeda S, Unemi N.

Gan To Kagaku Ryoho. 1994 Jun;21(7):1001-8. Japanese.

PMID:
8210249
17.

Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.

NĂ©mati F, Daniel C, Arvelo F, Legrier ME, Froget B, Livartowski A, Assayag F, Bourgeois Y, Poupon MF, Decaudin D.

Anticancer Drugs. 2010 Jan;21(1):25-32. doi: 10.1097/CAD.0b013e3283300a29.

PMID:
19823076
18.

[Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].

Fujita F, Fujita M, Sakamoto Y, Taguchi T.

Gan To Kagaku Ryoho. 1993 Feb;20(2):215-21. Japanese.

PMID:
8382036
19.

Etoposide prior to cis-diamminedichloroplatinum in combination chemotherapy: in vitro and in vivo studies.

Zupi G, Greco C, Sacchi A, Calabresi F.

Eur J Cancer Clin Oncol. 1985 Dec;21(12):1501-6.

PMID:
3830728
20.

Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.

Soriano AF, Helfrich B, Chan DC, Heasley LE, Bunn PA Jr, Chou TC.

Cancer Res. 1999 Dec 15;59(24):6178-84.

Supplemental Content

Support Center